Skip to main content
    G

    GE HealthCare Technologies Inc. (GEHC)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ

    $70.35
    +1.88 (+2.75%)

    Market Cap: $31.15B

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    87%(13/15)
    Avg Surprise
    +7.72%
    Streak
    1 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$1.20
    Range$1.18 - $1.25
    16 analysts
    EPS RevisionsNo revisions (7d)
    0
    13
    30d
    EPS Estimate DriftChange to current
    90d ago$1.24-3.2%
    60d ago$1.20-0.0%
    30d ago$1.20-0.0%
    7d ago$1.200.0%
    Current$1.20
    Revenue Consensus
    $5.4B
    Range$5.3B - $5.4B
    17 analysts
    Period ending Dec 31, 2026
    EPS Consensus$1.64
    Range$1.49 - $1.71
    20 analysts
    Revenue Consensus
    $6.1B
    Range$5.9B - $6.2B
    20 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$1.64---
    Sep 26EST
    		-$1.20---
    Jun 26
    Reported Jul 29
    		$1.13$1.04+8.65%Beat+6.6%
    Mar 26
    Reported Apr 29
    		$0.99$1.05-5.71%Miss-2.0%
    Dec 25
    Reported Feb 4
    		$1.44$1.40+2.86%Beat-8.3%
    Sep 25
    Reported Oct 29
    		$1.07$1.05+1.90%Beat-6.1%
    Jun 25
    Reported Jul 30
    		$1.06$0.92+15.22%Beat+6.0%
    Mar 25
    Reported Apr 30
    		$1.01$0.91+10.99%Beat+12.2%
    Dec 24
    Reported Feb 13
    		$1.57$1.26+24.60%Beat+33.1%
    Sep 24
    Reported Oct 30
    		$1.14$1.05+8.57%Beat+15.2%
    Jun 24
    Reported Jul 31
    		$1.00$0.98+2.04%Beat+8.7%
    Mar 24
    Reported Apr 30
    		$0.90$0.91-1.10%Miss+5.9%
    Dec 23
    Reported Feb 6
    		$1.18$1.07+10.28%Beat-2.5%
    Sep 23
    Reported Oct 31
    		$0.99$0.90+10.00%Beat-10.8%
    Jun 23
    Reported Jul 25
    		$0.92$0.87+5.75%Beat-51.6%
    Mar 23
    Reported Apr 25
    		$0.85$0.79+7.59%Beat-
    Dec 22
    Reported Jan 30
    		$1.21$1.06+14.15%Beat-
    Sep 22
    Reported Dec 8
    		$1.11$0.00N/ABeat-
    Jun 22
    Reported Sep 13
    		$1.90$0.00N/ABeat-

    Dividends

    Dividend Metrics

    Forward Yield0.20%
    Forward Annual Dividend$0.14
    Payout Ratio3.02%
    FrequencyQuarterly
    Pay MonthsFeb, May, Aug, Nov
    GEHC dividend history and ex-dividend datesRun GEHC in the free DRIP calculator

    Key Metrics

    Valuation
    P/E Ratio15.19EV/EBITDA10.79x
    Price/FCF20.18xFCF Yield4.95%
    Profitability
    Profit Margin9.33%Operating Margin15.00%
    ROE19.40%ROIC11.30%
    Financial Health
    Debt/Equity0.92xInterest Coverage7.23x
    Current Ratio1.26xQuick Ratio0.97x
    Trading Statistics
    Beta0.85Avg Volume3.93M
    52-Week High$89.6452-Week Low$58.72

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$66.48
    SMA 20$66.08
    SMA 50$68.61
    SMA 200$70.50
    EMA 10$67.29
    EMA 20$66.76
    EMA 50$67.08
    EMA 200$69.11

    MACD

    Line: 0.26Signal: -0.43Hist: 0.69

    ADX

    ADX: 20.4+DI: 33.6-DI: 15.5

    Aroon & PSAR

    Aroon Up100.0
    Aroon Down20.0
    PSAR$64.00

    Bollinger Bands

    Upper Band$69.52
    Lower Band$62.65
    %B Position1039%(Upper)
    Band Width1.12

    RSI (14-Day)

    Neutral
    65.1

    Momentum Oscillators

    Stoch %K88.5
    Stoch %D85.6
    Williams %R-8.3
    ROC (10d)10.0%
    Momentum6.37
    CCI (20d)230.0
    MFI (14d)59.7

    Volatility Measures

    ATR (14d)$1.72(2.4%)
    StdDev (20d)1.72
    Hist Vol24.0%(Moderate)

    Volume Flow

    VWAP$70.28
    OBV61.5M
    AD Line-189.7M
    CMF (20d)0.102

    Volume Metrics

    Avg Vol (20d)3.9M
    Vol Ratio1.0x
    VWMA (20d)$66.03

    Pivot Points

    R3$71.28
    R2$70.40
    R1$69.43
    Pivot Point$68.55
    S1$67.58
    S2$66.70
    S3$65.73

    Advanced Oscillators

    TSI4.06
    Ultimate Osc63.2
    KST-24.84

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$5.29B$5.13B$5.70B$5.14B$5.01B$4.78B$5.32B$4.86B$4.84B$4.65B$5.21B$4.82B
    Cost of Revenue$3.12B$3.15B$3.44B$3.15B$3.02B$2.77B$3.04B$2.84B$2.84B$2.75B$3.05B$2.89B
    Gross Profit$2.18B$1.98B$2.26B$1.99B$1.99B$2.01B$2.27B$2.03B$2.00B$1.90B$2.16B$1.94B
    Operating Expenses$1.44B$1.46B$1.43B$1.34B$1.33B$1.38B$1.47B$1.35B$1.39B$1.36B$1.47B$1.32B
    R&D$323.00M$345.00M$322.00M$292.00M$302.00M$344.00M$344.00M$316.00M$327.00M$324.00M$315.00M$322.00M
    SG&A$1.12B$1.12B$1.11B$1.04B$1.03B$1.04B$1.13B$1.03B$1.07B$1.04B$1.15B$996.00M
    Operating Income$739.00M$515.00M$827.00M$653.00M$654.00M$629.00M$801.00M$676.00M$608.00M$540.00M$689.00M$617.00M
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$114.00M$96.00M$106.00M$111.00M$113.00M$110.00M$121.00M$130.00M$131.00M$122.00M$131.00M$138.00M
    Income Before Tax$693.00M$505.00M$820.00M$643.00M$613.00M$692.00M$833.00M$658.00M$578.00M$512.00M$609.00M$636.00M
    Income Tax Expense$119.00M$94.00M$218.00M$179.00M$113.00M$104.00M$96.00M$168.00M$143.00M$124.00M$193.00M$250.00M
    Net Income$573.00M$411.00M$602.00M$464.00M$500.00M$588.00M$737.00M$490.00M$435.00M$388.00M$416.00M$382.00M
    EBITDA$966.00M$755.00M$1.07B$902.00M$874.00M$938.00M$1.09B$930.00M$859.00M$782.00M$884.00M$927.00M
    EBIT$806.00M$602.00M$926.00M$754.00M$726.00M$802.00M$955.00M$787.00M$710.00M$634.00M$740.00M$774.00M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about GEHC

    News

    Research conducted at University of Michigan published in Anesthesia & Analgesia Practice demonstrates GE HealthCare End-tidal Control software may help to reduce fresh gas flow

    A study conducted at the University of Michigan and published in *Anesthesia & Analgesia Practice* demonstrates that GE HealthCare's End-tidal Control software can significantly reduce fresh gas flow and sevoflurane...

    BioSpace•10/16/26•Bullish

    ISRG Ahead of Q3 Earnings: Can Procedure Growth Sustain Momentum?

    Intuitive Surgical (ISRG) is set to announce its Q3 2026 earnings, with expectations of continued adoption of its robotic-assisted surgery platforms despite moderating U.S. procedure growth and competitive pressures...

    The Globe and Mail•10/16/26•Neutral

    A study of 12,818 anesthesia cases linked GE HealthCare software to 39.3% less anesthetic use.

    GE HealthCare announced research from the University of Michigan showing its End-tidal Control software reduced fresh gas flow by 62.3% and sevoflurane consumption by 39.3% in a study of nearly 13,000 adult general...

    Stock Titan•10/16/26•Bullish

    ISRG Ahead of Q3 Earnings: Can Procedure Growth Sustain Momentum?

    Intuitive Surgical (ISRG) is set to report Q3 2026 earnings, with expectations of continued adoption of robotic-assisted surgery platforms despite moderating U.S. procedure growth and competitive pressures in China....

    TradingView•10/16/26•Neutral

    Stryker’s $400M Funding In CMR Surgical ‘Gives It Another Potential Growth Vertical,’ Analysts Say

    Stryker's $400 million investment in CMR Surgical, which includes exclusive US sales rights and a buyout option...

    Medtech Insight•10/15/26•Neutral

    GEHC Valuation and Fair Value

    P/E
    15.2x
    Forward P/E
    12.1x
    EV/EBITDA
    10.8x
    P/FCF
    20.2x
    PEG
    1.6x
    P/B
    2.9x
    See GNG's fair value

    GEHC Profitability: Margins, ROIC and FCF

    Gross margin
    39.5%
    Operating margin
    15.0%
    Net margin
    9.3%
    ROIC
    11.3%
    ROE
    19.4%
    FCF margin
    7.4%
    FCF yield
    5.0%

    GEHC Competitors

    CompanyTicker
    DexCom IncDXCM
    Zoetis IncZTS
    Mettler-Toledo International IncMTD
    West Pharmaceutical Services IncWST
    ResMed IncRMD
    Laboratory Corporation of America HoldingsLH
    Royalty Pharma PlcRPRX
    Quest Diagnostics IncorporatedDGX

    Sector: Healthcare

    GEHC Analyst Ratings

    Consensus
    Buy
    Analysts
    20
    Strong Buy
    5
    Buy
    10
    Hold
    5
    Sell
    0
    Strong Sell
    0

    GEHC Bull Case vs Bear Case

    Bull case

    • GEHC beat EPS estimates in 87.5% of its last 8 reported quarters.
    • 75.0% of GEHC's analyst ratings are Buy or Strong Buy.

    GEHC Earnings: Beat Rate and Next Report

    Beat rate
    7 of 8 quarters (87.5%)
    Average surprise
    8.4%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $1.20
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    0 up, 13 down

    GEHC Dividend

    Forward yield
    0.2%
    Payout ratio
    3.0%
    Pay months
    Feb, May, Aug, Nov
    GEHC dividend history

    Frequently Asked Questions About GEHC

    What is GEHC's current dividend yield?

    GE HealthCare Technologies Inc. (GEHC) has a forward dividend yield of 0.20%.

    Does GEHC pay dividends?

    Yes, GE HealthCare Technologies Inc. pays dividends with a forward dividend yield of 0.20%.

    What is GEHC's P/E ratio?

    GE HealthCare Technologies Inc. has a price-to-earnings (P/E) ratio of 15.19.

    What is GEHC's market cap?

    GE HealthCare Technologies Inc. (GEHC) has a market capitalization of $31.15B with a current stock price of $70.35.

    Related stocks

    Sector: Healthcare

    All stocks starting with G

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In